HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2015 - 2025)

HUTCHMED (China) (HCM) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $225.4 million in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 37.53% year-over-year to $225.4 million in Q4 2025; TTM through Dec 2025 was $3.4 billion, a 25.85% increase from a year earlier, with the FY2025 full-year figure at $225.4 million, up 38.03% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $225.4 million, down from $1.8 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for HCM reached as high as $1.8 billion in Q2 2025 and fell as low as $163786.0 in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $744.7 million across 5 years, with a median of $693.1 million in 2021.
• Across the five-year window, Liabilities and Shareholders Equity plunged 99.88% in 2023 and soared 99970.22% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $176.2 million in 2021, then slipped by 25.32% to $131.6 million in 2022, then sank by 99.88% to $163786.0 in 2023, then surged by 99970.22% to $163.9 million in 2024, then soared by 37.53% to $225.4 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $225.4 million in Q4 2025, $1.8 billion in Q2 2025, and $163.9 million in Q4 2024.